Fresenius Kabi USA, LLC recalls Famotidine Injection
- Published
- 3 Dec 2025
- Units affected
- 2,199,850 vials
- Agency
- FDA
- Country
- United States
The hazard
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, LLC, NDC 63323-739-11 (unit of use), 63323-739-12 (unit of sale).
- Brand / company
- Fresenius Kabi USA, LLC
- Codes / lots
- Lot #: 6133156, 6133194, Exp Date: 08/2026; 6133388, Exp Date: 10/2026.
- Distribution
- Nationwide within the United States as well as AK, HI, and PR.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 3 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.